Description
Key Development:
In March 2021, Global specialty glass maker Schott delivered glass vials for over 1 billion doses of COVID-19 vaccines. The company planned to offer vials for more than 2 billion vaccine doses in 2021.
$ PRICE - $ 3,000.00 – $ 8,900.00
Vaccine Vials Market: By Type (Single Dose, Multi Dose), By Material (Glass, Polymer) and Geograpy
In March 2021, Global specialty glass maker Schott delivered glass vials for over 1 billion doses of COVID-19 vaccines. The company planned to offer vials for more than 2 billion vaccine doses in 2021.
Pharmaceutical firms are increasingly adopting stringent packaging criteria to protect medicine contents and avoid drug-container contact. As a result, pharmaceutical companies are favoring vials for packaging.
The Asia-Pacific market is expected to witness the largest market share during the forecast period.
The vaccine vials market is projected to expand at a CAGR of 10.6% during the forecast period.
The major players in the global vaccine vials market are Anhui Huaxin Medicinal Glass Products Co., Ltd., Berlin Packaging LLC, Corning Inc., Cardinal Health, DWK Life Sciences GmbH, Gerresheimer AG, Jinan Youlyy Industrial Co., Ltd, JOTOP Glass, Nipro Corporation, Origin Pharma Packaging, Pacific Vial Manufacturing Inc, Qorpak, Inc.
Asia-Pacific is the fastest-growing region for vaccine vials market
1. Executive Summary |
2. Global Vaccine Vials Market Introduction |
2.1. Global Vaccine Vials Market – Taxonomy |
2.2. Global Vaccine Vials Market –Definitions |
2.2.1. By Type |
2.2.2. By Material |
2.2.3. By Region |
3. Global Vaccine Vials Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Vaccine Vials Market Dynamic Factors – Impact Analysis |
3.6. Global Vaccine Vials Market – Competition Landscape |
4. Global Vaccine Vials Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 |
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Vaccine Vials Market, By Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1. Single Dose |
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Multi Dose |
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Vaccine Vials Market, By Material, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.1. Glass |
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Polymer |
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7. Global Vaccine Vials Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.1. North America |
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia-Pacific |
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Middle East and Africa |
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Global Vaccine Vials Market – Opportunity Analysis Index, By Type, Material, and Region, 2022 – 2028 |
8. North America Vaccine Vials Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
8.1.1. Single Dose |
8.1.2. Multi Dose |
8.2. Material Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
8.2.1. Glass |
8.2.2. Polymer |
8.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
8.3.1. USA |
8.3.2. Canada |
8.4. North America Vaccine Vials Market – Opportunity Analysis Index, By Type, Material, and Country, 2022 – 2028 |
8.5. North America Vaccine Vials Market Dynamics – Trends |
9. Europe Vaccine Vials Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Single Dose |
9.1.2. Multi Dose |
9.2. Material Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.2.1. Glass |
9.2.2. Polymer |
9.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Germany |
9.3.2. UK |
9.3.3. France |
9.3.4. Spain |
9.3.5. Italy |
9.3.6. Russia |
9.3.7. Rest of Europe |
9.4. Europe Vaccine Vials Market – Opportunity Analysis Index, By Type, Material, and Country, 2022 – 2028 |
9.5. Europe Vaccine Vials Market Dynamics – Trends |
10. Asia-Pacific Vaccine Vials Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
10.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Single Dose |
10.1.2. Multi Dose |
10.2. Material Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Glass |
10.2.2. Polymer |
10.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.3.1. China |
10.3.2. India |
10.3.3. Japan |
10.3.4. ASEAN |
10.3.5. Australia & New Zealand |
10.3.6. Rest of Asia-Pacific |
10.4. Asia-Pacific Vaccine Vials Market – Opportunity Analysis Index, By Type, Material, and Country, 2022 – 2028 |
10.5. Asia-Pacific Vaccine Vials Market Dynamics – Trends |
11. Latin America Vaccine Vials Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
11.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Single Dose |
11.1.2. Multi Dose |
11.2. Material Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Glass |
11.2.2. Polymer |
11.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Brazil |
11.3.2. Mexico |
11.3.3. Argentina |
11.3.4. Rest of Latin America |
11.4. Latin America Vaccine Vials Market – Opportunity Analysis Index, By Type, Material, and Country, 2022 – 2028 |
11.5. Latin America Vaccine Vials Market Dynamics – Trends |
12. Middle East and Africa Vaccine Vials Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
12.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Single Dose |
12.1.2. Multi Dose |
12.2. Material Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Glass |
12.2.2. Polymer |
12.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Gulf Cooperation Council (GCC) Countries |
12.3.2. Israel |
12.3.3. South Africa |
12.3.4. Rest of MEA |
12.4. MEA Vaccine Vials Market – Opportunity Analysis Index, By Type, Material, and Country, 2022 – 2028 |
12.5. MEA Vaccine Vials Market Dynamics – Trends |
13. Competition Landscape |
13.1. Strategic Dashboard of Top Market Players |
13.2. Company Profiles (Introduction, Financial Analysis, Type Offerings, Key Developments, Strategies, and SWOT Analysis) |
13.2.1. Cardinal Health, Inc. |
13.2.2. Berlin Packaging LLC |
13.2.3. SCHOTT AG |
13.2.4. Richland Glass Company, Inc. |
13.2.5. Gerresheimer AG |
13.2.6. Thermo Fisher Scientific Inc |
13.2.7. Catalent, Inc. |
13.2.8. Nipro Corporation |
13.2.9. DWK Life Sciences GmbH |
13.2.10. Vetter Pharma-Fertigung GmbH & Co. KG |
14. Research Methodology |
15. Key Assumptions and Acronyms |
In March 2021, Global specialty glass maker Schott delivered glass vials for over 1 billion doses of COVID-19 vaccines. The company planned to offer vials for more than 2 billion vaccine doses in 2021.
Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072
Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX
Design & Developed By WEQ Technologies
Design & Developed By WEQ Technologies
Reviews
There are no reviews yet.